Home > Products > CD2 & EGFR
> Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Fab-IgG)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Fab-IgG) (CAT#: FABIG-046)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Fab-IgG) is designed to be expressed as three chains, assembling in vivo and resulting in the construct of Fab-IgG (Tandem Fab-Fc). Fab-IgG has standard Fab and Fc domains, with no mutations, which may permit it has similar affinity binding and PK profile comparable to the parental antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Fab-IgG) (FABIG-046). Click the button below to contact us or submit your feedback about this product.